1 Finsterer J. Management of cryptogenic stroke[J].Acta Neurol Belg, 2010, 110:135-147.2 管强, 聂志余. 反常栓塞与隐源性卒中[J]. 中华内科杂志, 2014, 53:149-150.3 Larrue V, Massabuau P. Patent foramen ovale andischemic stroke[J]. Minerva Med, 2012, 6:199-207.4 Bronzetti G, Angelo C, Donti A, et al. Role of atrialfibrillation after transcatheter closure of patentforamen ovale in patients with or without cryptogenicstroke[J]. Inter J Cardiol, 2011, 146:17-21.5 Windecker S, Meier B. Patent foramen ovale andatrial septal aneurysm:When and how should they betreated[J]. ACC Curr J Rev, 2002, 11:97-101.6 吴美华. 卵圆孔未闭的研究进展[J]. 心血管病学进展,2007, 5:122-124.7 杨帆, 林晶. 有不明原因脑卒中的卵圆孔未闭患者封堵治疗的循证依据[J]. 心血管病学进展, 2010, 31:147-149.8 Handke M, Harloff A, Olschewski M, et a1. Patentforamen ovale and cryptogenic stroke in olderpatients[J]. N Engl J Med, 2007, 357:2262-2268.9 Mas J, Cabanes L. Atrial septal aneurysmand patentforamen transesophageal echocardiography[J]. Stroke,1993, 24:1865-1873.10 Komar M, Podolec P, Przewlocki T, et al. Transoesophagealechocardiography can help distinguish betweenpatients with symptomatic and asymptomatic patentforamen ovale[J]. Kardiol Pol, 2012, 70:1258-1263.11 Klotz S, Gebhard M, Sievers HH. Late left atrialthrombosis of an Amplatzer patent foramen ovaleoccluder[J]. J Thorac Cardiovasc Surg, 2011,142:1270-1271.12 Ghosh S, Ghosh AK, Ghosh S. Patent foramen ovaleand atrial septal aneurysm in cryptogenie stroke[J].Postgrad Med J, 2007, 83:173-177.13 Demir M, Ozmen G, Kecoglu S, et al. Right and leftatrial appendage function in patients with atrial septalaneurysm without patent foramen ovale[J]. ActaCardiol, 2012, 67:457-460.14 Faughnan ME, Palda VA, Garcia-Tsao G, etal. International guidelines for the diagnosisand management of hereditary haemorrhagictelangiectasia[J]. J Med Genet, 2011, 48:73-87.15 Cottin V, Dupuis-Girod S, Lesca G, et al. Pulmonaryvascular manifestations of hereditary hemorrhagictelangieetasia(Rendu-Osler disease)[J]. Respiration,2007, 74:361-378.16 Sen S, Hinderliter A, Sen PK, et al. Aortic archatheroma progression and recurrent vascular eventsin patients with stroke or transient ischemic attack[J].Circulation, 2007, 116:928-935.17 Harloff A, Simon J, Brendecke S, et al. Complexplaques in the proximal descending aorta:anunderestimated embolic source of stroke[J]. Stroke,2010, 41:1145-1150.18 Karalis DG, Chandrasekaran K, Victor MF, et al.Recognition and embolic potential of intraaorticatherosclerotic debris[J]. J Am Coll Candiol, 1991,17:73-78.19 程学英, 王剑锋. 缺血性卒中不可忽视的病因——脑动脉夹层[J]. 中国实用内科杂志, 2014, 5:457-459.20 Leys D, Bandu L, Henon H, et al. Clinical outcomein 287 consecutive young adults (15-45years) withischemic stroke[J]. Neurology, 2002, 59:26-33.21 Stefan T, Tobias B, Stphanie D, et al. Antiplateletsversus anticoagulation in cervical artery dissection[J].Stroke, 2007, 38:2605-2611.22 Cacciapuoti F. Hyper-homocysteineimia:a novelrisk factor or a powerful marker for cardiovasculardiseases? Pathogenetic and therapeuticaluncertainties[J]. J Thromb Thromolysis, 2011, 32:82-88.23 Stehouwer CD, van Guldener C. Does homocysteinecause hypertension[J]. Clin Chem Lab Med, 2003,41:1408-1411.24 Clarke R, Armitage J, Lewington S, et al.Homocysteine-lowering trials for prevention ofvascular disease:protocol for a collaborative meta-analysis[J]. Clin Chem Lab Med, 2007, 45:1575-1581.25 Bagi Z, Ungvari Z, Koller A. Xanthine oxidase-derived reactive oxygen species convert flow-induced arteriolar dilation to constrictionin hyperhomocysteinemia:possible role ofperoxynitrite[J]. Arterioscler Thromb Vasc Biol, 2002,22:28-33.26 中华医学会呼吸病学分会睡眠呼吸障碍学组. 阻塞性睡眠吸暂停低通气综合征诊治指南(2011年修订版)[J].中华结核和呼吸杂志, 2012, 35:9-12.27 Bassetti CL, HermannDM. Sleep and stroke[J]. HandbClin Neurol, 2011, 99:1051-1072.28 Yaggi HK, Concato J, Kernan WN, et al. Obstructivesleep apnea as a risk factor for stroke and death[J]. NEngl J Med, 2005, 353:2034-2041.29 吴波娜, 刘文华, 徐格林, 等. 阻塞性睡眠呼吸暂停综合征与脑血管病的关系研究进展[J]. 中华老年心脑血管病杂志, 2010, 12:188-191.30 Eikermann-Haerter K, Hyun Lee J, Yuzawa I, et al.Migraine mutations increase stroke vulnerability byfacilitating ischemic depolarizations[J]. Circulation,2012, 125:335-345.31 Dalkara T, Nozari A, Moskowitz MA. Migraineaura pathophysiology:the role of blood vessels andmicroembolisation[J]. Lancet Neurol, 2010, 9:309-317.32 Bousser MG, Welch KM. Relation between migraineand stroke[J]. Lancet Neurol, 2005, 4:533-542.33 刘立海, 吕秀东. 隐源性卒中病因学研究进展[J]. 疑难病杂志, 2012, 7:564-568.34 Perko D, Pretnar-Oblak J, Sabovic M, et al.Cerebrovascular reactivity to L-arginine in theanterior and posterior cerebral circulation in migrainepatients[J]. Acta Neurol Scand, 2011, 24:269-274.35 Bohlega S. Novel mutation of the notch3 gene inArabic family with CADASIL[J]. Neurol Int, 2011,3:e6.36 Chabriat H, Joutel A, Dichgans M, et al. CADASIL[J].Lancet Neurol, 2009, 8:643-653.37 Brennan-Krohn T, Salloway S, Correia S, et al. Glialvascular degeneration in CADASIL[J]. J AlzheimersDis, 2010, 21:1393-1402.38 鲁明, 樊东升. Fabry病与卒中[J]. 中国卒中杂志, 2012,2:114-119.39 Feldt-Rasmussen U. Fabry disease and early stroke[J].Stroke Res Treat, 2011, 2011:615218.40 Baptista MV, Ferreira S, Pinho-E-Melo T, et al.Mutations of the GLA gene in young patients withstroke:the PORTYSTROKE study-screening geneticconditions in Portuguese young stroke patients[J].Stroke, 2010, 4l:431-436.41 Moore DF, Kaneski CR, Askari H, et al. The cerebralvasculopathy of Fabry disease[J]. J Neurol Sci, 2007,257:258-263.42 Hara K, Shiga A, Fukutake T, et al. Association ofHTRA1 mutations and familial ischemic cerebralsmall-vessel disease[J]. N Eng J Med, 2009, 360:1729-1739.43 Oide T, Nakayama H, Yanagawa S, et al. Extensiveloss of arterial medial smooth muscle cells andmural extracellular matrix in cerebral autosomalrecessive arteriopathy with subcortical infarcts andleukoencephalopathy (CARASIL)[J]. Neuropathology,2008, 28:132-142. |